Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Mar, 22 2024
Oct, 9 2025
Oct, 31 2025
Dec, 10 2025
Oct, 10 2025